Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : VB-1953
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Results demonstrate that VB-1953 with its dual mechanism of action directly kills resistant and non-resistant C. acnes strains while blocking inflammation through TLR-MD2 inhibition, is a safe and effective topical treatment for facial acne.
Product Name : VB-1953
Product Type : Antibiotic
Upfront Cash : Inapplicable
June 16, 2020
Lead Product(s) : VB-1953
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
